What Could New and Promising Treatment Options Mean for CLL Patients?

patientpower has 1556 videos Subscribe Here

Description: A new treatment, ibrutinib (Imbruvica), was recently approved by the Food and Drug Administration (FDA) for use in CLL patients who have received at least one previous therapy. Dr. Susan O'Brien, a leading CLL expert from MD Anderson Cancer Center, joins us to explain what she feels this new option--and other promising treatments in development--could mean for some CLL patients.

Get email alerts | http://www.patientpower.inf...

Subscribe on YouTube |
Like on Facebook |
Follow on Twitter |
Shared By : patientpower
Posted on : 02/19/14
Added : 3 years ago
Category : Other